Mephenytoin is used to treat refractory partial epilepsy. Mephenytoin is a solid. This compound belongs to the phenylhydantoins. These are heterocyclic aromatic compounds containing an imiazolidinedione moiety substituted by a phenyl group. Mephenytoin is known to target sodium channel protein type 5 subunit alpha. Cytochrome P450 2C19, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2B6, Cytochrome P450 1A2, and Cytochrome P450 2D6 are known to metabolize mephenytoin. Mephenytoin is a hydantoin-derivative anticonvulsant used to control various partial seizures. Mephenytoin and oxazolidinedione derivatives are associated with higher incidences of blood dyscrasias compared to other anticonvulsants. Its therapeutic use is listed as anti-epileptic drugs, anticonvulsants and central nervous system (CNS) agents. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include Methoin and Methylphenetoin. Its PubChem CID is 4060.
Mephenytoin
| CAS No | 50-12-4 |
|---|---|
| Molecular Formula | C12H14N2O2 |
| Molecular Weight | 218.25 g/mol |
| Synonyms | 5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mephenytoin is used to treat refractory partial epilepsy. Mephenytoin is a solid. This compound belongs to the phenylhydantoins. These are heterocyclic aromatic compounds containing an imiazolidinedione moiety substituted by a phenyl group.
The listed CAS number is 50-12-4.
The listed molecular formula is C12H14N2O2.
The listed molecular weight is 218.25 g/mol.
5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione.
The source lists Methoin and Methylphenetoin.